Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

This real-world study tracks how a radioactive drug called lutetium-177 PSMA (used to treat advanced prostate cancer) is used and how well it works in patients across China in everyday clinical settings outside of a controlled trial. **You may be eligible if...** - You are an adult male diagnosed with metastatic castration-resistant prostate cancer (mCRPC) or metastatic hormone-sensitive prostate cancer (mHSPC) - Your doctor has decided to treat you with lutetium-177 PSMA as part of your normal care - You have adequate organ function as assessed by your medical team **You may NOT be eligible if...** - You are currently enrolled in another interventional clinical trial - You are already participating in another Novartis-sponsored non-interventional study using the same drug Talk to your doctor to see if this trial is right for you.